文献速递临床试验与 GCP

香槟方促进腹部术后胃肠功能恢复(XBPRS试验):随机对照试验研究方案

Xiangbin prescription for the recovery of gastrointestinal function after abdominal surgery (the XBPRS trial): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-02-27

本研究为双盲随机对照临床试验,拟纳入腹腔镜直肠癌根治术或腹腔镜良性病变全子宫切除术患者,评估香槟方(XBP)预防术后肠梗阻和加速胃肠功能恢复的疗效与安全性。主要结局为首次排气、排便、正常肠鸣音及流质/半流质/普食时间,并评价GCP标准下的疗效安全性和胃饥饿素机制。

要点

  • 香槟方用于腹部术后胃肠功能恢复尚缺乏随机对照试验证据。
  • 主要结局包括首次排气、排便、肠鸣音恢复及饮食过渡时间。
  • 试验同时评估GCP标准下的疗效安全性和胃饥饿素机制。

核心结论

  • 该试验旨在评估香槟方预防术后肠梗阻和加速腹部术后胃肠功能恢复的疗效与安全性。

研究设计与样本

  • 双盲随机对照临床试验,纳入腹腔镜直肠癌根治术或腹腔镜良性病变全子宫切除术后胃肠动力障碍患者。

关键数值与推荐

  • 主要结局为首次排气时间、排便时间、正常肠鸣音恢复时间及流质/半流质/普食时间。
  • 同时按GCP标准评估疗效与安全性,并客观研究胃饥饿素作用机制。

临床怎么用

  • 若试验证实有效,香槟方可作为腹部术后促进胃肠功能恢复的标准化中药方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Most patients who undergo abdominal surgery recover bowel movements within a week; however, some suffer prolonged intestinal paralysis or postoperative ileus (POI) leading to complications, such as infection and intestinal adhesions, which can extend hospitalization and increase readmission rates, and consequently increasing healthcare costs. Chinese medicine is effective for accelerating the recovery of gastrointestinal function after abdominal surgery. Xiangbin prescription (XBP) is the standard prescription for this purpose in our hospital; however, randomized controlled trials of it have not yet been conducted. METHODS/DESIGN: This double-blind, randomized controlled clinical trial aims to recruit patients who have undergone abdominal surgery and experienced postoperative dysmotility to evaluate the efficacy and safety of XBP for preventing POI and accelerating recovery. The research will tackle the common problem of slow recovery of gastrointestinal function after surgery. The participants will be patients who undergo laparoscopic radical resection of rectal carcinoma or laparoscopic panhysterectomy of a benign lesion. Primary outcome measures will be time to first flatus, defecation, normal bowel sounds, and liquid/semi-liquid/general diet. Good Clinical Practice (GCP) standards of efficacy and safety will also be evaluated, along with objective investigation of the mechanism of action of ghrelin. DISCUSSION: This pivotal trial will be a standardized, scientific, clinical trial designed to evaluate the use of XBP for the recovery of gastrointestinal function after surgery, and it will conform to international standards for clinical trials for the recognition of traditional Chinese medicine. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ID: ChiCTR-TRC-14004156 . Registered on 3 January 2014.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Gan H, Lin J, Jiang Z, et al. Xiangbin prescription for the recovery of gastrointestinal function after abdominal surgery (the XBPRS trial): study protocol for a randomized controlled trial. Trials. 2018. PMID: 29486765. doi:10.1186/s13063-018-2484-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。